Literature DB >> 32350569

LncRNA promoted inflammatory response in ischemic heart failure through regulation of miR-455-3p/TRAF6 axis.

Qianqian Gu1, Bin Wang2, Hongying Zhao3, Wenjuan Wang3, Pengsheng Wang3, Yu Deng3.   

Abstract

OBJECTIVES: Ischemic heart failure (IHF) is the most common cause of death globally. Growing evidence shows abnormal expression of long non-coding RNAs in heart failure patients. This study aims to investigate the effect of sex-determining region Y-box 2 (SOX2) overlapping transcript (SOX2-OT) on the regulation of the inflammatory response in ischemic heart failure.
METHODS: IHF rat and oxygen and glucose deprivation (OGD) cell models were established. qRT-PCR was employed to investigate the expression of SOX2-OT. ELISA, western blot and cell viability/apoptosis assays were performed to assess the effects of SOX2-OT. Online software program was used to identify miRNAs that target SOX2-OT, followed by validation using RNA pull-down. Potential targets of miRNAs were searched, and examined by immunoblotting, qRT-PCR and luciferase reporter assay.
RESULTS: SOX2-OT was up-regulated in IHF and OGD. Knockdown of SOX2-OT promoted cell proliferation, decreased apoptosis rate and cell oxidative damage, and ameliorated inflammatory response. SOX2-OT contains binding sites for miR-455-3p, miR-5586-3p and miR-1252-5p. RNA pull-down confirmed the binding ability between SOX2-OT and miR-455-3p. TRAF6 is a direct target of miR-455-3p. Moreover, the regulatory activity of SOX2-OT on inflammatory response was partially through its negative regulation of miR-455-3p, which directly regulates TRAF6. Down-regulation of SOX2-OT improved myocardial dysfunction in IHF rat.
CONCLUSIONS: Our results reveal that SOX2-OT may be a driver of IHF through repression of miR-455-3p, and miR-455-3p alleviates IHF by targeting TRAF6. Therefore, SOX2-OT/miR-455-3p/TRAF6 may be a potential target for advanced therapeutic strategy for IHF.

Entities:  

Keywords:  Inflammatory response; Ischemic heart failure; NF-κb; SOX2-OT; TRAF6

Year:  2020        PMID: 32350569     DOI: 10.1007/s00011-020-01348-8

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  7 in total

1.  LncRNA SNHG15 Knockdown Protects Against OGD/R-Induced Neuron Injury by Downregulating TP53INP1 Expression via Binding to miR-455-3p.

Authors:  Yun Fan; Lihong Wei; Sanjun Zhang; Xueyun Song; Jiaqing Yang; Xiaoxia He; Xianzhao Zheng
Journal:  Neurochem Res       Date:  2021-02-02       Impact factor: 3.996

2.  LncRNA SOX2-OT/miR-30d-5p/PDK1 Regulates PD-L1 Checkpoint Through the mTOR Signaling Pathway to Promote Non-small Cell Lung Cancer Progression and Immune Escape.

Authors:  Zhoumiao Chen; Zhao Chen; Shaohua Xu; Qiang Zhang
Journal:  Front Genet       Date:  2021-07-30       Impact factor: 4.599

3.  Mesenchymal stem cell extracellular vesicles-derived microRNA-194-5p delays the development of intervertebral disc degeneration by targeting TRAF6.

Authors:  Zhongyi Sun; Xiaoming Tang; Qiuyuan Li; Haibin Wang; Hongzhi Sun; Jiwei Tian
Journal:  Regen Ther       Date:  2022-01-20       Impact factor: 3.419

4.  LncRNA SOX2-OTinhibitionprotects against myocardialischemia/reperfusion-inducedinjury via themicroRNA-186-5p (miR-186-5p)/Yin Yang 1 (YY1)pathway.

Authors:  Pengjie Yang; Kun Liang; Weisong Wang; Dehua Zhou; Yuan Chen; Xueyan Jiang; Rong Fu; Benben Zhu; Xuefeng Lin
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

Review 5.  Long non-coding RNAs in the pathogenesis of heart failure: A literature review.

Authors:  Xiaoyan Fan; Zhenwei Zhang; Liang Zheng; Wei Wei; Zetao Chen
Journal:  Front Cardiovasc Med       Date:  2022-08-03

6.  Depression of long non-coding RNA SOX2 overlapping transcript attenuates lipopolysaccharide-induced injury in bronchial epithelial cells via miR-455-3p/phosphatase and tensin homolog axis and phosphatidylinositol 3-kinase/protein kinase B pathway.

Authors:  Chunhua Yi; Tijun Gu; Yongchang Li; Qian Zhang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 7.  LncRNA: A Potential Target for Host-Directed Therapy of Candida Infection.

Authors:  Ye Wang; Hongdan Xu; Na Chen; Jin Yang; Hongmei Zhou
Journal:  Pharmaceutics       Date:  2022-03-11       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.